From Name:
From Email:
To Name:
To Email:

Optional Message:


Roche and Exelixis head to the FDA with their melanoma combo

from FierceBiotech

Partners Roche and Exelixis are making their case to regulators with a melanoma-treating combination therapy, filing an FDA application for the fast-tracked treatment as they await European clearance. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063